GHRP-2 and Ipamorelin are synthetic research peptides commonly used together in experimental models to investigate growth hormone axis regulation and pituitary receptor signaling. GHRP-2 is a potent hexapeptide growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R1a), stimulating Gq/PLC-dependent calcium signaling involved in GH release and endocrine feedback mechanisms. Ipamorelin is a selective pentapeptide GHS-R1a agonist that promotes GH secretion through calcium-mediated pathways while demonstrating minimal interaction with other pituitary hormone systems in preclinical studies. The combined use of these peptides in research settings allows for the investigation of complementary GHS-R1a signaling dynamics, receptor pharmacology, and somatotropic pathway modulation.
Disclaimer: All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion. The products and statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). These compounds are intended for laboratory research use only. They are not for human consumption, medical, veterinary, or household use. Nothing on this website should be construed as medical advice or as a substitute for professional medical consultation. By purchasing, you agree that you are a qualified researcher and understand the proper handling and storage of these materials.